TOP TEN perturbations for 39567_at (Homo sapiens)
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
Organism: Homo sapiens
Gene: 39567_at
Selected probe(set): 206955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39567_at (206955_at) across 6674 perturbations tested by GENEVESTIGATOR:
breast cancer study 8 (metastatic) / normal breast tissue
Relative Expression (log2-ratio):-4.1503353Number of Samples:2 / 4
| Experimental | breast cancer study 8 (metastatic) |
| Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 8 (primary) / normal breast tissue
Relative Expression (log2-ratio):-3.7866306Number of Samples:13 / 4
| Experimental | breast cancer study 8 (primary) |
| Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer. | |
| Control | normal breast tissue |
| Normal human breast samples of healthy female individuals. |
breast cancer study 15 (inv. dc) / normal breast tissue
Relative Expression (log2-ratio):-2.8427095Number of Samples:5 / 5
| Experimental | breast cancer study 15 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 15 (dc is) / normal breast tissue
Relative Expression (log2-ratio):-2.6211376Number of Samples:9 / 5
| Experimental | breast cancer study 15 (dc is) |
| Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery. | |
| Control | normal breast tissue |
| Tissue samples of the breast from healthy female individuals after breast reduction surgery. |
breast cancer study 16 (inv. lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.6073675Number of Samples:5 / 27
| Experimental | breast cancer study 16 (inv. lc) |
| Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (inv. dc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.5864267Number of Samples:22 / 27
| Experimental | breast cancer study 16 (inv. dc) |
| Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue
Relative Expression (log2-ratio):-2.4377394Number of Samples:4 / 27
| Experimental | breast cancer study 16 (mix. inv. dc lc) |
| Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery. | |
| Control | adjacent breast tissue |
| Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer. |
sarcoidosis study 6 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.3521023Number of Samples:7 / 22
| Experimental | sarcoidosis study 6 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from sarcoidosis. Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |
alopecia areata study 1 (AT; lesional; validation) / normal skin tissue (validation)
Relative Expression (log2-ratio):2.31106Number of Samples:3 / 13
| Experimental | alopecia areata study 1 (AT; lesional; validation) |
| Lesional scalp skin punch biopsies obtained from patients who suffered from alopecia areata totalis (AT) assigned to validation dataset. | |
| Control | normal skin tissue (validation) |
| Scalp skin punch biopsies obtained from healthy donors assigned to validation dataset. |
granulomatosis with polyangiitis study 3 (orbital adipose tissue) / normal orbital adipose tissue
Relative Expression (log2-ratio):-2.2657824Number of Samples:9 / 22
| Experimental | granulomatosis with polyangiitis study 3 (orbital adipose tissue) |
| Orbital adipose tissue samples obtained from patients who suffered from granulomatosis with polyangiitis (GPA). Biopsies were formalin-fixed and paraffin-embedded. | |
| Control | normal orbital adipose tissue |
| Normal orbital adipose tissue samples. Samples were obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. Biopsies were formalin-fixed and paraffin-embedded. |